Replies to post #199445 on Biotech Values

[DewDiligence]

TTHI -20%—LLY dumps TT401 program in T2D:

http://finance.yahoo.com/news/transition-therapeutics-provides-type-2-100100580.html

The phase-2 data were not great (#msg-120218895).